A pilot study using neuropsychological testing from the Arimidex, Tamoxifen ... [13] Since this 2004 study, aromatase inhibitor use and any effect on cognition remain under consideration.

Arimidex is an aromatase inhibitor, indicated primarily for the adjuvant treatment of postmenopausal women with hormone receptor-positive early breast cancer. It is also used as first-line ...

Large, randomized clinical trials comparing tamoxifen to either tamoxifen sequenced with an AI or an AI at initiation of endocrine therapy for early-stage breast cancer have demonstrated efficacy ...